Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 14, 2009
Grant Date -
May 22, 2003
app pub date -
Jan 11, 2002
filing date -
Oct 1, 1996
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention is directed to pharmaceutical compositions comprising a telomerase reverse transcriptase polypeptide or a polypeptide homologous to a telomerase reverse transcriptase. The present invention is also directed to pharmaceutical compositions comprising a polynucleotide encoding either of the aforesaid polypeptides. The present invention is further directed to methods for eliciting an immune response to telomerase reverse transcriptase in a subject.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully